Cargando…
An Apolipoprotein A-I Mimetic Peptide Designed with a Reductionist Approach Stimulates Reverse Cholesterol Transport and Reduces Atherosclerosis in Mice
Apolipoprotein A-I (apoA-I) mimetic peptides are considered a promising novel therapeutic approach to prevent and/or treat atherosclerosis. An apoA-I mimetic peptide ELK-2A2K2E was designed with a reductionist approach and has shown exceptional activity in supporting cholesterol efflux but modest an...
Autores principales: | Ditiatkovski, Michael, D’Souza, Wilissa, Kesani, Rajitha, Chin-Dusting, Jaye, de Haan, Judy B., Remaley, Alan, Sviridov, Dmitri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706315/ https://www.ncbi.nlm.nih.gov/pubmed/23874769 http://dx.doi.org/10.1371/journal.pone.0068802 |
Ejemplares similares
-
Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases
por: Wolska, Anna, et al.
Publicado: (2021) -
Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux
por: Islam, Rafique M., et al.
Publicado: (2018) -
Apolipoprotein Mimetic Peptides: A New Approach for the Treatment of Asthma
por: Yao, Xianglan, et al.
Publicado: (2012) -
Skeletal Muscle Insulin Resistance Associated with Cholesterol-Induced Activation of Macrophages Is Prevented by High Density Lipoprotein
por: Carey, Andrew L., et al.
Publicado: (2013) -
Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis
por: Getz, Godfrey S, et al.
Publicado: (2011)